Michael Steinberg

Summary

Affiliation: Massachusetts College of Pharmacy and Health Sciences
Country: USA

Publications

  1. pmc Academic performance in a pharmacotherapeutics course sequence taught synchronously on two campuses using distance education technology
    Michael Steinberg
    Massachusetts College of Pharmacy and Health Sciences, Worcester, 01608, USA
    Am J Pharm Educ 75:150. 2011
  2. doi request reprint Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma
    Michael Steinberg
    Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Clin Ther 32:821-43. 2010
  3. doi request reprint Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer
    Michael Steinberg
    Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Clin Ther 31:2312-31. 2009
  4. doi request reprint Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer
    Michael Steinberg
    Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Clin Ther 30:1590-617. 2008
  5. ncbi request reprint Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    Michael Steinberg
    Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, 19 Foster Street, Worcester, MA 01608, USA
    Clin Ther 29:2289-308. 2007
  6. doi request reprint Ustekinumab: treatment of adult moderate-to-severe chronic plaque psoriasis
    James V Scanlon
    School of Pharmacy, Biogen Idec Massachusetts College of Pharmacy and Health Sciences, Worcester Manchester, MA 01608, USA
    Ann Pharmacother 43:1456-65. 2009
  7. doi request reprint Rivaroxaban for thromboprophylaxis in patients undergoing major orthopedic surgery
    Stephanie N Melillo
    Biogen Idec Massachusetts College of Pharmacy and Health Sciences, School of Pharmacy Worcester Manchester, Worcester, MA 01608, USA
    Ann Pharmacother 44:1061-71. 2010
  8. doi request reprint Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia
    Maryann R Cooper
    Massachusetts College of Pharmacy and Health Sciences, Worcester Manchester, MA, USA
    Ann Pharmacother 45:1094-102. 2011
  9. doi request reprint Efficacy and safety of modafinil in the treatment of cancer-related fatigue
    Maryann R Cooper
    Massachusetts College of Pharmacy and Health Sciences, Worcester, Manchester, NH 03101, USA
    Ann Pharmacother 43:721-5. 2009
  10. ncbi request reprint Mild serotonin syndrome associated with concurrent linezolid and fluoxetine
    Michael Steinberg
    Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Am J Health Syst Pharm 64:59-62. 2007

Collaborators

Detail Information

Publications12

  1. pmc Academic performance in a pharmacotherapeutics course sequence taught synchronously on two campuses using distance education technology
    Michael Steinberg
    Massachusetts College of Pharmacy and Health Sciences, Worcester, 01608, USA
    Am J Pharm Educ 75:150. 2011
    ..To compare the academic performance of campus-based students in a pharmacotherapeutics course with that of students at a distant campus taught via synchronous teleconferencing...
  2. doi request reprint Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma
    Michael Steinberg
    Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Clin Ther 32:821-43. 2010
    ..Plerixafor, a bicyclam molecule that acts as a pure antagonist of chemokine receptor-4, is approved by the US Food and Drug Administration for use in combination with G-CSF for mobilization of CD34+ HSC in patients with NHL or MM...
  3. doi request reprint Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer
    Michael Steinberg
    Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Clin Ther 31:2312-31. 2009
    ..Although effective, these agents have limitations, such as a flare-up of cancer symptoms within the first 2 weeks of starting the drug...
  4. doi request reprint Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer
    Michael Steinberg
    Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Clin Ther 30:1590-617. 2008
    ....
  5. ncbi request reprint Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    Michael Steinberg
    Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, 19 Foster Street, Worcester, MA 01608, USA
    Clin Ther 29:2289-308. 2007
    ..The oral TK inhibitor dasatinib was approved in 2006 for use in patients with CML or Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) who are unable to tolerate or have not responded to other treatments...
  6. doi request reprint Ustekinumab: treatment of adult moderate-to-severe chronic plaque psoriasis
    James V Scanlon
    School of Pharmacy, Biogen Idec Massachusetts College of Pharmacy and Health Sciences, Worcester Manchester, MA 01608, USA
    Ann Pharmacother 43:1456-65. 2009
    ..To systematically review the pharmacology, pharmacokinetics, clinical efficacy, and safety profile of ustekinumab to inform pharmacists and other healthcare professionals of this new biologic therapy for psoriasis...
  7. doi request reprint Rivaroxaban for thromboprophylaxis in patients undergoing major orthopedic surgery
    Stephanie N Melillo
    Biogen Idec Massachusetts College of Pharmacy and Health Sciences, School of Pharmacy Worcester Manchester, Worcester, MA 01608, USA
    Ann Pharmacother 44:1061-71. 2010
    ....
  8. doi request reprint Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia
    Maryann R Cooper
    Massachusetts College of Pharmacy and Health Sciences, Worcester Manchester, MA, USA
    Ann Pharmacother 45:1094-102. 2011
    ..To evaluate the use of oral, single-agent, broad-spectrum fluoroquinolones in the treatment of low-risk febrile neutropenia (FN)...
  9. doi request reprint Efficacy and safety of modafinil in the treatment of cancer-related fatigue
    Maryann R Cooper
    Massachusetts College of Pharmacy and Health Sciences, Worcester, Manchester, NH 03101, USA
    Ann Pharmacother 43:721-5. 2009
    ..Reference citations from articles identified were reviewed...
  10. ncbi request reprint Mild serotonin syndrome associated with concurrent linezolid and fluoxetine
    Michael Steinberg
    Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA
    Am J Health Syst Pharm 64:59-62. 2007
    ..A case of serotonin syndrome that developed during concurrent linezolid and fluoxetine is presented...
  11. ncbi request reprint Advances in pharmacotherapy for tobacco dependence
    Jonathan Foulds
    UMDNJ School of Public Health
    Expert Opin Emerg Drugs 9:39-53. 2004
    ..g., frequency of injections required) before they can become widely used and successful therapies. The best hope of improved treatment comes from combining existing and new pharmacotherapies with effective behavioural therapy...